Cargando…
Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection
INTRODUCTION: Conbercept is a new anti-vascular endothelial growth factor drug approved for the treatment of age-related macular degeneration by the China Food and Drug Administration (CFDA) in 2013. In this study, we for the first time evaluated the concentrations of vascular endothelial growth fac...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250636/ https://www.ncbi.nlm.nih.gov/pubmed/30377995 http://dx.doi.org/10.1007/s13300-018-0527-9 |